Allianz Asset Management GmbH - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 53 filers reported holding PROQR THRAPEUTICS N V in Q4 2019. The put-call ratio across all filers is 1.25 and the average weighting 0.3%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q1 2020$134,000
-85.9%
24,400
-74.6%
0.00%
-100.0%
Q4 2019$953,000
+426.5%
96,070
+208.7%
0.00%
Q3 2019$181,000
-48.6%
31,125
-19.4%
0.00%
Q2 2019$352,000
-39.7%
38,625
-8.4%
0.00%
-100.0%
Q1 2019$584,000
-4.7%
42,145
+8.0%
0.00%0.0%
Q4 2018$613,00039,0100.00%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q4 2019
NameSharesValueWeighting ↓
Privium Fund Management B.V. 5,344,446$4,156,0001.38%
Prosight Management, LP 1,707,509$1,328,0001.05%
Opaleye Management Inc. 2,740,000$2,131,0000.96%
M28 Capital Management LP 1,001,800$779,0000.87%
Monaco Asset Management SAM 931,400$724,0000.32%
APOGEM CAPITAL LLC 125,273$97,0000.09%
Ground Swell Capital, LLC 21,640$17,0000.03%
FRANKLIN STREET ADVISORS INC /NC 150,000$117,0000.01%
Atom Investors LP 30,422$24,0000.01%
ADAGE CAPITAL PARTNERS GP, L.L.C. 3,300,000$2,566,0000.01%
View complete list of PROQR THRAPEUTICS N V shareholders